Table 1 Demographic and clinical information by FKBP5 rs1360780 genotype group

From: The role of FKBP5 genotype in moderating long-term effectiveness of exposure-based psychotherapy for posttraumatic stress disorder

  C/C (N=13) C/T (N=15) T/T (N=15) Statistic a P-value
N female (%) 9 (69) 9 (60) 11 (73) Fisher’s exact test 0.78
Mean age (s.d.) 35.38 (10.40) 30.60 (13.06) 30.20 (10.52) H2=3.58 0.17
Mean traumatic load (s.d.) 35.92 (5.54) 38.07 (7.06) 35.93 (7.25) F2,40=0.50 0.61
Mean number of sessions (s.d.) 11.46 (2.18) 11.67 (2.50) 12 (1.46) H2=2.03 0.36
Mean PDS score (t1) (s.d.) 17.69 (4.44) 16.47 (4.76) 16.8 (5.27) H2=0.70 0.70
Mean PDS intrusions score (t1) (s.d.) 4.85 (2.51) 3.87 (2.45) 5.20 (2.01) F2,40=1.32 0.28
Mean PDS avoidance score (t1) (s.d.) 6.38 (2.10) 6.67 (1.88) 5.47 (2.07) H2=3.68 0.16
Mean PDS hyperarousal score (t1) (s.d.) 6.46 (2.15) 5.93 (1.91) 6.13 (3.48) H2=0.77 0.68
Mean M.I.N.I. suicidality score (t1) (s.d.) 12.69 (8.31) 12.13 (10.21) 11.67 (12.49) H2=0.40 0.82
  1. Abbreviations: ANOVA, analysis of variance; M.I.N.I., Mini International Neuropsychiatric Interview; PDS, Posttraumatic Diagnostic Scale.
  2. aANOVA F-test for continuous data if test residuals were normally distributed, Kruskal–Wallis H-test for continuous data if residuals were not normally distributed and Fisher’s exact test for categorical data.